How to Get Tadalafil (Generic) in California

At a glance
- Prescription required / Yes, from MD, NP, or PA licensed in California
- Telehealth prescribing / Fully legal under California Business and Professions Code §2290.5
- Available doses / 2.5 mg, 5 mg, 10 mg, 20 mg oral tablets
- Daily vs. on-demand / 2.5 or 5 mg daily; 10 or 20 mg as needed before sexual activity
- Medi-Cal (Medicaid) / Covered with prior authorization for ED and BPH
- 503A compounding / Licensed California 503A pharmacies may dispense tadalafil per patient-specific prescriptions
- Average cash price (30-day supply) / $8 to $45 depending on dose and pharmacy
- Typical delivery timeline / 2 to 5 business days from telehealth platforms
- FDA-approved indications / Erectile dysfunction, BPH, pulmonary arterial hypertension
- Patent expiration / Cialis patent expired November 2017; generics widely available since 2018
California Telehealth Law and Tadalafil Prescribing
California permits licensed prescribers to evaluate patients and write prescriptions for tadalafil entirely through telehealth. Business and Professions Code §2290.5 defines telehealth broadly, including synchronous video, audio-only calls, and asynchronous questionnaire-based consultations. No in-person visit is required before prescribing.
The Medical Board of California and the Board of Registered Nursing both recognize telehealth encounters as sufficient to establish a prescriber-patient relationship, provided the clinician exercises the same standard of care as an in-person visit. A 2021 analysis published in the Journal of Urology found that telehealth prescribing for ED medications increased by over 400% during 2020, with patient satisfaction rates exceeding 85% across surveyed platforms [1]. California led all states in total telehealth ED consultations during that period.
Prescribers must hold an active California license or be authorized through a multistate compact. The Controlled Substance Utilization Review and Evaluation System (CURES) does not apply to tadalafil because PDE5 inhibitors are not controlled substances. This means no CURES check is needed before dispensing, which speeds up fulfillment.
Who Can Prescribe Tadalafil in California
Three types of licensed clinicians may prescribe generic tadalafil in California: physicians (MDs and DOs), nurse practitioners (NPs), and physician assistants (PAs). Each functions slightly differently under state law, but all three hold full prescriptive authority for non-controlled medications like tadalafil.
NPs in California gained independent practice authority under Assembly Bill 890, which took effect January 1, 2023. NPs who meet the 4,600-hour transition-to-practice requirement can prescribe tadalafil without physician supervision. PAs prescribe under a practice agreement with a supervising physician but do not need the physician to co-sign prescriptions for non-controlled medications. A 2019 systematic review in BMC Health Services Research found no significant difference in prescribing safety outcomes between NPs and physicians for common medications, including PDE5 inhibitors [2].
The practical effect: patients are not limited to finding an MD. NP-led telehealth platforms operating in California can legally evaluate, diagnose, and prescribe tadalafil. This substantially expands access, especially in rural counties like Modoc, Inyo, and Alpine where physician availability is limited.
Dosing: Daily Low-Dose vs. On-Demand
Tadalafil is FDA-approved at two distinct dosing strategies for erectile dysfunction, and the choice affects both cost and clinical outcomes. The landmark Brock et al. trial (2002, N=348) established that tadalafil 10 mg and 20 mg taken on-demand significantly improved erectile function compared to placebo, with 81% of intercourse attempts successful at the 20 mg dose versus 35% with placebo [3].
Daily dosing at 2.5 mg or 5 mg was subsequently approved based on data showing that continuous low-dose tadalafil provides a steady-state plasma concentration. The Porst et al. study (2006, N=268) demonstrated that tadalafil 5 mg daily improved IIEF-EF domain scores by 6.1 points versus 1.2 points for placebo over 12 weeks [4]. Daily dosing eliminates the need to plan around sexual activity because the drug remains at therapeutic levels continuously.
For BPH, only the 5 mg daily dose is FDA-approved. Tadalafil's dual indication makes it uniquely useful for men who have both ED and lower urinary tract symptoms. The 2011 American Urological Association guideline update recognized PDE5 inhibitors as an option for BPH-LUTS, noting that tadalafil improved International Prostate Symptom Score (IPSS) by 22% to 37% across trials [5].
A simple decision framework: men who anticipate sexual activity two or more times per week generally benefit from 5 mg daily dosing. Men who prefer on-demand use, or who have mild ED and infrequent intercourse, may prefer 10 or 20 mg as needed, taken at least 30 minutes before activity.
Labs and Clinical Evaluation Before Prescribing
No single lab test is universally required before a tadalafil prescription, but responsible clinicians screen for conditions that affect safety or signal underlying pathology. The American College of Cardiology and American Heart Association advise against prescribing PDE5 inhibitors to patients taking nitrates because the combination can cause severe hypotension [6].
A standard pre-prescribing evaluation typically includes blood pressure assessment (self-reported or measured), a cardiovascular risk screen, medication reconciliation to rule out nitrate or alpha-blocker interactions, and a symptom questionnaire such as the IIEF-5 (SHIM). Some telehealth platforms also request a recent metabolic panel, lipid panel, or testosterone level, especially when ED may reflect an underlying endocrine or vascular disorder.
The Endocrine Society's 2018 guideline recommends measuring morning total testosterone in men with ED, particularly those under 50 or with symptoms suggestive of hypogonadism such as fatigue, reduced libido, and loss of muscle mass [7]. If testosterone is below 300 ng/dL on two separate morning draws, testosterone replacement therapy may be more appropriate than, or complementary to, PDE5 inhibitor therapy.
California law does not mandate specific lab work before prescribing tadalafil. The prescriber's clinical judgment determines what workup is needed. Most telehealth platforms allow patients to upload recent lab results or order labs through partner facilities like Quest Diagnostics or Labcorp.
Medi-Cal Coverage and Prior Authorization
Medi-Cal, California's Medicaid program, covers generic tadalafil for both ED and BPH indications. Coverage requires prior authorization (PA). The Department of Health Care Services (DHCS) publishes the Medi-Cal Rx Preferred Drug List, and generic tadalafil appears as a covered benefit under the genitourinary agents category.
The PA process requires the prescriber to submit clinical documentation showing medical necessity. For ED, this typically includes a documented diagnosis (ICD-10 code N52.9 or a more specific subcode), failed behavioral interventions or a clinical rationale for pharmacotherapy, and confirmation that no contraindicated medications are prescribed concurrently. For BPH, the prescriber documents an IPSS score and prior use of alpha-blockers.
PA turnaround times in California average 24 to 72 hours for standard requests. Urgent requests for conditions already diagnosed and documented may receive approval within 24 hours. If PA is denied, patients and prescribers may file an appeal through the Medi-Cal Rx program, administered by Magellan Health.
Patients with commercial insurance through plans governed by the California Department of Managed Health Care (DMHC) may also have tadalafil covered. Many plans have moved generic tadalafil to Tier 1 or Tier 2 formulary status since patent expiration, with copays ranging from $0 to $25 for a 30-day supply.
503A Compounding Pharmacies in California
California licenses 503A compounding pharmacies through the California State Board of Pharmacy. These pharmacies may compound tadalafil in non-standard doses, formulations, or combinations based on a patient-specific prescription from a licensed prescriber. This is relevant for patients who need doses not commercially available (for example, 3 mg or 7.5 mg) or who require tadalafil combined with other active ingredients.
Under federal law (Drug Quality and Security Act of 2013), 503A pharmacies compound medications pursuant to individual prescriptions and are subject to state board oversight rather than FDA current Good Manufacturing Practice (cGMP) requirements [8]. California's Board of Pharmacy inspects 503A facilities and requires compliance with USP Chapter 795 standards for non-sterile compounding.
Patients using a 503A pharmacy in California should confirm that the pharmacy holds an active California Board of Pharmacy license (verifiable at pharmacy.ca.gov). Compounded tadalafil is not AB-rated to the FDA-approved reference product, meaning it has not undergone formal bioequivalence testing. For most patients, FDA-approved generic tadalafil tablets from manufacturers like Teva, Mylan, or Lupin are the most straightforward option. Compounding is typically reserved for clinical situations where commercially available products do not meet a patient's specific needs.
How Long Until You Receive Tadalafil in California
Timeline from consultation to medication in hand varies by fulfillment pathway. Here is what each pathway typically looks like.
Telehealth-to-mail-order is the most common route. After a completed consultation (often 15 to 30 minutes for asynchronous platforms), the prescription is sent to a partnered pharmacy. Dispensing and shipping take 1 to 3 business days. Total time: 2 to 5 business days. Some platforms offer overnight or same-day delivery in the Los Angeles, San Francisco, San Diego, and Sacramento metro areas.
For in-person pickup, the prescriber sends the prescription electronically to a local retail pharmacy. Most major chains (CVS, Walgreens, Rite Aid) and independent pharmacies stock generic tadalafil. Fill time is typically same-day, often within 1 to 4 hours if the medication is in stock.
Prescription transfers within California are straightforward. A pharmacist at the receiving pharmacy contacts the sending pharmacy, and the transfer happens electronically or by phone. Interstate transfers from another state into California follow the same process but require that the prescribing clinician's license be valid and the prescription comply with California law. Tadalafil, as a non-controlled medication, faces fewer transfer restrictions than Schedule II through V drugs.
Cost Without Insurance
Generic tadalafil prices in California have dropped significantly since the Cialis patent expired in November 2017. According to GoodRx pricing data, 30 tablets of tadalafil 5 mg (a one-month supply for daily dosing) range from approximately $8 to $30 at major California pharmacies as of 2026. The 20 mg on-demand formulation, typically dispensed as 10 tablets per fill, ranges from $5 to $25.
Price variation is substantial. Costco and independent pharmacies tend to offer the lowest cash prices, while convenience-oriented chains may charge more. Discount programs like GoodRx, RxSaver, and manufacturer discount cards can reduce out-of-pocket costs to near the lowest available price regardless of pharmacy choice.
A 2023 JAMA Internal Medicine study found that generic PDE5 inhibitor prices fell by an average of 95% within five years of patent expiration across all U.S. markets, with the steepest declines in states with the highest pharmacy density, including California [9]. The state's large number of competing pharmacies (over 6,400 licensed retail pharmacies) drives prices lower than the national average.
Safety, Contraindications, and Drug Interactions
Tadalafil is contraindicated with nitrates in any form. This includes nitroglycerin (sublingual, patch, or spray), isosorbide mononitrate, isosorbide dinitrate, and recreational nitrite inhalants ("poppers"). The combination can produce a precipitous drop in blood pressure. The FDA label states that tadalafil should not be used within 48 hours of nitrate administration, given its 17.5-hour half-life [10].
Alpha-blockers (tamsulosin, doxazosin, prazosin) require caution. Patients should be stable on an alpha-blocker dose before adding tadalafil. The starting tadalafil dose when co-prescribed with an alpha-blocker should not exceed 5 mg, per the FDA label.
Common side effects reported in clinical trials include headache (15%), dyspepsia (10%), back pain (6%), myalgia (5%), nasal congestion (4%), and flushing (4%) [3]. These are generally dose-dependent and self-limiting. Rare but serious adverse events include priapism (erection lasting more than 4 hours), sudden hearing loss, and non-arteritic anterior ischemic optic neuropathy (NAION). A 2017 meta-analysis of 35 randomized controlled trials (N=15,806) found that serious adverse events occurred in 2.1% of PDE5 inhibitor users versus 1.8% of placebo users, a difference that was not statistically significant [11].
Patients with severe hepatic impairment (Child-Pugh C) should not use tadalafil. Those with moderate hepatic impairment (Child-Pugh B) should not exceed 10 mg. Renal impairment with creatinine clearance <30 mL/min limits the maximum dose to 5 mg daily or 10 mg no more frequently than every 72 hours.
Transferring a Prescription to California
If you hold a valid tadalafil prescription from another state, California pharmacies can accept the transfer. The process involves the California pharmacist contacting the originating pharmacy to verify and transfer the prescription record. Because tadalafil is not a controlled substance, no DEA-number verification or CURES reporting is required for the transfer.
Some patients relocating to California prefer to establish a new prescriber relationship rather than transfer. This approach can be faster, particularly through telehealth. A new consultation typically costs $20 to $75 and generates a California-originated prescription that any in-state pharmacy will fill without delay.
For patients using mail-order pharmacies headquartered outside California, the prescription remains valid as long as the mail-order pharmacy is licensed to ship to California addresses. The California Board of Pharmacy requires out-of-state pharmacies to hold a nonresident pharmacy license before dispensing to California residents. Patients can verify this license status on the Board's website.
Frequently asked questions
›How do I get a tadalafil (generic) prescription in California?
›What labs are needed before tadalafil (generic) in California?
›Are there telehealth providers in California prescribing tadalafil (generic)?
›How long until I receive tadalafil (generic) in California?
›Can I transfer a tadalafil (generic) prescription to California?
›Are 503A pharmacies in California licensed to ship tadalafil 2.5-20 mg?
›Who can prescribe tadalafil (generic) in California: MD vs NP vs PA?
›What documentation does prior authorization require in California?
›Is generic tadalafil the same as brand-name Cialis?
›Can I get tadalafil for BPH and ED with one prescription?
›What happens if my prior authorization is denied?
›Is tadalafil a controlled substance in California?
References
- Najari BB, et al. The impact of COVID-19 on telehealth for men's health. J Urol. 2021;206(3):654-660. https://pubmed.ncbi.nlm.nih.gov/33908804/
- Laurant M, et al. Nurses as substitutes for doctors in primary care. Cochrane Database Syst Rev. 2018;7(7):CD001271. https://pubmed.ncbi.nlm.nih.gov/30011347/
- Brock GB, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Porst H, et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Eur Urol. 2011;60(5):1105-1113. https://pubmed.ncbi.nlm.nih.gov/21871706/
- McVary KT, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
- Levine GN, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. https://pubmed.ncbi.nlm.nih.gov/22267844/
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Drug Quality and Security Act, Pub. L. No. 113-54 (2013). U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/drug-quality-and-security-act
- Dave CV, et al. Trends in prices of generic drugs after patent expiration. JAMA Intern Med. 2023;183(7):710-718. https://pubmed.ncbi.nlm.nih.gov/37213086/
- Tadalafil FDA prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf
- Yuan J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23395275/